JMIR human factors

How People with Depression Experience Using Remote Symptom Tracking Technology Over Time

Updated

Abstract

A longitudinal qualitative study involved 124 interviews with 99 participants across three countries to explore long-term engagement with remote measurement technologies (RMTs) for major depressive disorder (MDD).

  • Five main themes emerged regarding the subjective experience of long-term RMT use: research-related factors, utility for self-management, technology-related factors, clinical factors, and necessary system amendments.
  • Participants highlighted both experiential factors, which reflect their personal engagement with RMTs, and system-related factors, which pertain to their direct interaction with the technologies.
  • Insights gathered may inform future recommendations for enhancing user engagement with RMTs in both research settings and clinical practice.
  • Understanding these themes is essential for promoting sustained use of RMTs among individuals managing MDD.

Simplified

Full Text

We can’t show the full text here under this license.

Funding

Competing interests

Conflicts of Interest: MH is the principal investigator of the RADAR-CNS program, a precompetitive public-private partnership funded by the Innovative Medicines Initiative and the European Federation of Pharmaceutical Industries and Associations. The program received support from Janssen, Biogen, Merck & Co, Union Chimique Belge, and Lundbeck. JMH has received economic compensation for participating in advisory boards or giving educational lectures from Eli Lilly & Co, Sanofi, Lundbeck, and Otsuka. CO is supported by the UK Medical Research Council (MR/N013700/1) and King’s College London member of the MRC Doctoral Training Partnership in Biomedical Sciences.
PubMed

What Lands in Your Inbox Each Week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free